Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,133
Closed -$91K 770
2021
Q4
$91K Sell
2,133
-101
-5% -$4.92K 0.01% 701
2021
Q3
$116K Buy
2,234
+636
+40% +$30.6K 0.01% 673
2021
Q2
$73K Buy
1,598
+760
+91% +$33.5K 0.01% 671
2021
Q1
$37K Buy
838
+274
+49% +$12K ﹤0.01% 616
2020
Q4
$21K Buy
+564
New +$20.1K ﹤0.01% 533
2020
Q3
Sell
-1,263
Closed -$57K 529
2020
Q2
$57K Buy
1,263
+580
+85% +$23.3K 0.01% 483
2020
Q1
$26K Sell
683
-1,219
-64% -$67.1K ﹤0.01% 403
2019
Q4
$120K Buy
1,902
+998
+110% +$61.3K 0.02% 454
2019
Q3
$54K Buy
904
+232
+35% +$15.9K 0.01% 452
2019
Q2
$47K Buy
672
+244
+57% +$14.6K 0.01% 402
2019
Q1
$22K Buy
+428
New +$26.7K ﹤0.01% 354

Other funds holding VEON

Corient Capital Partners's VEON Position: Q1 2022 in Review

Corient Capital Partners sold out of VEON (VEON) in Q1 2022, closing a stake of 2,133 shares — an estimated $91K sold.

Corient Capital Partners first reported a position in VEON in Q1 2019 and held it in 11 quarters. The position peaked at $120K in Q4 2019. 97 funds tracked by Wall St. Rank hold VEON as of Q1 2022.

  • Corient Capital Partners reported no remaining VEON position as of Q1 2022 after selling out during the quarter.
  • Corient Capital Partners sold 2,133 VEON shares in Q1 2022, an estimated $91K.
  • Corient Capital Partners first reported a position in VEON in Q1 2019 and held it in 11 quarters.
  • Corient Capital Partners's VEON position peaked at $120K in Q4 2019.
  • 97 funds tracked by Wall St. Rank held VEON as of Q1 2022.

Based on Corient Capital Partners's 13F filing for Q1 2022, filed 16 May 2022.